Gene · 10549
Papers1,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma concentrations of thioredoxin, thioredoxin reductase and peroxiredoxin-4 can identify high risk patients and predict outcome in patients with acute coronary syndrome: A clinical observation. | Int J Cardiol | 2024 | 38382848 | PubTator, text mining | PubMed |
| Peroxiredoxin-1 as a molecular chaperone that regulates glutathione S-transferase P1 activity and drives mutidrug resistance in ovarian cancer cells. | Biochem Biophys Rep | 2024 | 38288281 | PubTator, text mining | PubMed |
| The Tumor Suppressor SOCS1 Diminishes Tolerance to Oxidative Stress in Hepatocellular Carcinoma. | Cancers (Basel) | 2024 | 38254783 | PubTator, text mining | PubMed |
| The Clinical Relevance of the Expression of SGLT2 in Lung Adenocarcinoma. | Oncology | 2024 | 38232717 | PubTator, text mining | PubMed |
| Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review. | Neurooncol Adv | 2024 | 38221979 | PubTator, text mining | PubMed |
| Mediators of the association between albuminuria and incident cancer: the PREVEND study. | Clin Kidney J | 2024 | 38213496 | PubTator, text mining | PubMed |
| Analyzing secretory proteins in human dermal fibroblast-conditioned medium for angiogenesis: A bioinformatic approach. | Skin Res Technol | 2024 | 38200622 | PubTator, text mining | PubMed |
| Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis. | Heliyon | 2024 | 38173501 | PubTator, text mining | PubMed |
| Comparative Efficacy of Rosuvastatin Monotherapy and Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity and Vascular Inflammatory Response in Patients with Type 2 Diabetes Mellitus. | Diabetes Metab J | 2024 | 38173371 | PubTator, text mining | PubMed |
| Serum peroxiredoxin-4, a biomarker of oxidative stress, is associated with the development of nephropathy in patients with type 2 diabetes (Zodiac-65). | Free Radic Biol Med | 2024 | 38151214 | PubTator, text mining | PubMed |
| Identification of sulfhydryl-containing proteins and further evaluation of the selenium-tagged redox homeostasis-regulating proteins. | Redox Biol | 2024 | 38064764 | PubTator, text mining | PubMed |
| WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities. | Genes Dis | 2024 | 37692481 | PubTator, text mining | PubMed |
| Distinct or Overlapping Areas of Mitochondrial Thioredoxin 2 May Be Used for Its Covalent and Strong Non-Covalent Interactions with Protein Ligands. | Antioxidants (Basel) | 2023 | 38275635 | PubTator, text mining | PubMed |
| Leveraging technology-driven strategies to untangle omics big data: circumventing roadblocks in clinical facets of oral cancer. | Front Oncol | 2023 | 38234400 | PubTator, text mining | PubMed |
| Redox Biology and Liver Fibrosis. | Int J Mol Sci | 2023 | 38203581 | PubTator, text mining | PubMed |
| Analysis of the Differentially Expressed Proteins in Donkey Milk in Different Lactation Stages. | Foods | 2023 | 38137269 | PubTator, text mining | PubMed |
| ROS regulation in gliomas: implications for treatment strategies. | Front Immunol | 2023 | 38130720 | PubTator, text mining | PubMed |
| Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma. | Cancer Res | 2023 | 38098449 | PubTator, text mining | PubMed |
| Pan-Inhibition of Protein Disulfide Isomerase Caused Cell Death through Disrupting Cellular Proteostasis in Pancreatic Ductal Adenocarcinoma Cells. | Int J Mol Sci | 2023 | 38003657 | PubTator, text mining | PubMed |
| Novel Biomarkers and Advanced Cardiac Imaging in Aortic Stenosis: Old and New. | Biomolecules | 2023 | 38002343 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10549/papers?page=5